The company now expects full-year revenue to be $845 million to $865 million, up from the previous range of $820 million to ...

Actor Nicolas Cage will take on the biblical mantle of Joseph, the father of Jesus, in THE CARPENTER’S SON. Cage joins FKA Twigs as Mary and Noah Jupe as Jesus in horror movie that follows the family ...

The San Diego County Board of Supervisors backed the controversial proposed Harmony Grove Village South development outside Escondido on Wednesday, following a years-long battle by neighbors. The ...

SAN DIEGO (FOX 5/KUSI) — A controversial plan to add hundreds of homes to an unincorporated area near Escondido faces a key vote by county supervisors on Wednesday afternoon. Harmony Grove Village ...

Fifth Harmony singer Lauren Jauregui delivered a savage one-word reply after being eliminated from “Dancing With the Stars” Tuesday night. When asked how she was feeling about ending her short time on ...

NORTH HARMONY — A town man is facing a number of cruelty to animals charges after 10 dogs were poisoned. At 9:20 a.m. Wednesday, sheriff’s deputies and the Chautauqua County Humane Society responded ...

Harmony Biosciences Holdings, Inc. is downgraded from Buy to Hold after a failed Phase 3 trial for ZYN002 in Fragile X syndrome. HRMY's pipeline setback and sNDA rejection raise concerns about ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...

CLEVELAND, Ohio - Cleveland city councilman Brian Kazy and other members of the city council will present Bone Thugs -N-Harmony with the third annual The Music Keynote to the City at a ceremony at 3 p ...

Sept 24 (Reuters) - Harmony Biosciences (HRMY.O), opens new tab said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its ...

Harmony Biosciences’ $60 million bet on a once-failed Fragile X candidate has gone off the rails. Two years after picking up ZYN002 despite a midphase flop, the biotech has reported that a ...